Literature DB >> 11112040

Cancer incidence in a kidney-transplanted population.

L Kyllönen1, K Salmela, E Pukkala.   

Abstract

A study on cancer incidence after kidney transplantation was performed using data of national transplant and cancer registries. Since 1964 up to 30 June 1997, 3440 kidney transplantations were performed on 2890 patients. From 1967 to 1997, 230 posttransplantation malignancies were found in 20,817 patient-years of follow up. The standardised incidence ratio (SIR) was 3.33 compared to the general population. The SIR was highest in skin cancer (39.2). The SIRs were high in cancers of the lip (23.0), thyroid (8.08), kidney (8.0), lower urinary tract (3.2), non-Hodgkin lymphoma (4.8), ovary (3.9) and colon (3.9). Skin cancer and lymphomas had much higher SIRs in men than in women whereas lower urinary tract cancer had a higher SIR in women. During the first 10 follow up years, life-table analysis indicates a higher cancer risk in cyclosporine-treated patients, but this may be biased by their shorter follow up as the overall SIR was equal in both groups. This population study shows the increased incidence of cancer in the transplant population and points out the importance of cancer surveillance in the years following kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112040     DOI: 10.1007/s001470050369

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  33 in total

1.  Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Authors:  Howard D Strickler
Journal:  J Natl Cancer Inst       Date:  2009-07-31       Impact factor: 13.506

Review 2.  Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Nephrol Dial Transplant       Date:  2015-02-03       Impact factor: 5.992

Review 3.  Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review.

Authors:  Jian Zhang; Linlin Ma; Zelin Xie; Yuwen Guo; Wen Sun; Lei Zhang; Jun Lin; Jing Xiao; Yichen Zhu; Ye Tian
Journal:  Med Oncol       Date:  2014-06-08       Impact factor: 3.064

4.  Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies.

Authors:  Weifeng Shang; Liu Huang; Li Li; Xiaojuan Li; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  Mol Clin Oncol       Date:  2016-07-07

5.  Gastrointestinal complications in renal transplant recipients detected by endoscopic biopsies in a developing country.

Authors:  Muhammed Ishaque; Rahma Rashid; Muhammed Mubarak
Journal:  Indian J Gastroenterol       Date:  2015-03-12

Review 6.  Malignancy and systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Ann Clarke; Rosalind Ramsey-Goldman
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

7.  Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.

Authors:  M Safaeian; H A Robbins; S I Berndt; C F Lynch; J F Fraumeni; E A Engels
Journal:  Am J Transplant       Date:  2016-01-05       Impact factor: 8.086

8.  Treatment of advanced rectal cancer in a patient after combined pancreas-kidney transplantation.

Authors:  T T Zittel; C F R Mehl; U Reichmann; H D Becker; E C Jehle
Journal:  Langenbecks Arch Surg       Date:  2003-10-22       Impact factor: 3.445

9.  Cancer incidence in kidney transplant recipients: a study protocol.

Authors:  Salvador Pita-Fernandez; Francisco Valdes-Cañedo; Sonia Pertega-Diaz; Maria Teresa Seoane-Pillado; Rocio Seijo-Bestilleiro
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

10.  Glucocorticoid therapy and risk of bladder cancer.

Authors:  K Dietrich; A Schned; J Fortuny; J Heaney; C Marsit; K T Kelsey; M R Karagas
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.